January 7, 2025 - 02:06

Nvidia has officially launched its highly anticipated RTX 50 series of graphics chips during the CES 2025 event. This new lineup includes a range of powerful desktop and laptop graphics cards, with the flagship model, the RTX 5090, priced at $1,999.
The RTX 50 series promises significant advancements in gaming performance, featuring cutting-edge technology that enhances ray tracing capabilities and overall rendering quality. Gamers can expect smoother frame rates and more immersive experiences, thanks to the improved architecture and increased processing power of these new chips.
In addition to the RTX 5090, Nvidia has introduced several other models in the series, catering to a variety of gaming needs and budgets. The company emphasizes its commitment to pushing the boundaries of graphics technology, aiming to meet the demands of both casual and professional gamers alike. As the gaming landscape continues to evolve, Nvidia's RTX 50 series is poised to set new standards in visual fidelity and performance.
March 27, 2026 - 07:31
Asian stocks mostly lower after Wall Street's worst day since start of Iran warFinancial markets across the Asia-Pacific region traded mostly lower on Friday, mirroring a severe downturn on Wall Street. The negative sentiment stemmed from growing investor doubts over a...
March 26, 2026 - 20:50
Better Home & Finance, Coinbase to offer mortgage backed by cryptocurrenciesA new financial partnership is bridging the worlds of digital assets and real estate. A novel mortgage program will allow prospective homebuyers to leverage their cryptocurrency investments to...
March 26, 2026 - 05:31
Is Gold a Smart Investment for Your 2026 Portfolio?As investors look ahead to 2026, many are questioning whether gold deserves a place in their financial strategy. Historically, the precious metal has been revered as a safe-haven asset, often...
March 25, 2026 - 01:51
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial ResultsPOMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31,...